Ian T. Clark
EVP-COMMERCIAL OPERATIONS, GENENTECH INC.
Companies
- Takeda Pharmaceutical CompanyBoard member Mar 18, 2026 to now1
- BioMarin PharmaceuticalBoard member Aug 5, 2025 to now2
- GoodRxBoard member Jul 10, 2024 to now3
- Kyverna Therapeutics, Inc.Board member Feb 7, 2024 to now4
- Olema Pharmaceuticals, Inc.Board member Nov 18, 2020 to now5
- Guardant HealthBoard member Oct 3, 2018 to now6
- Corvus Pharmaceuticals, Inc.Board member Jan 4, 2017 to now7
- Tectonic Therapeutic, Inc.Board member Jun 20, 2018 to Jun 8, 20238
- Agios PharmaceuticalsBoard member Jan 4, 2017 to May 24, 20229
- Kite PharmaBoard member Jan 5, 2017 to Oct 5, 201710
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
BioMarin Pharmaceutical BMRN14,490 shares11$793.3K at $54.75Jun 2, 2026
Guardant Health GH2,975 shares12$473.1K at $159.04Aug 4, 2026
GoodRx GDRX100,150 shares13$338.5K at $3.38Jul 8, 2025
Agios Pharmaceuticals AGIO6,549 shares14$225.0K at $34.36May 20, 2022
Takeda Pharmaceutical Company TAK9,700 shares15$190.5K at $19.64Mar 18, 2026- Kyverna Therapeutics, Inc. KYTX21,727 shares16$126.1K at $5.80May 27, 2026
- Olema Pharmaceuticals, Inc. OLMA0 shares17Dec 19, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 4, 2026Sold 5,092 shares at $158.80 of Guardant Health12
- Aug 4, 2026Sold 9,088 shares at $158.98 of Guardant Health12
- Aug 4, 2026Exercised options 6,833 shares at $50.57 of Guardant Health12
- Aug 4, 2026Exercised options 2,255 shares at $91.11 of Guardant Health12
- Jun 17, 2026Exercised options 5,092 shares of Guardant Health18
- Jun 2, 2026Granted 7,490 shares of BioMarin Pharmaceutical11
- May 27, 2026Granted 5,093 shares of Kyverna Therapeutics, Inc.16
- May 20, 2026Sold 6,876 shares at $106.90 of Guardant Health19
- Dec 19, 2025Sold 41,840 shares at $30.48 of Olema Pharmaceuticals, Inc.17
- Dec 19, 2025Sold 193,056 shares at $29.71 of Olema Pharmaceuticals, Inc.17
- Dec 19, 2025Sold 29,904 shares at $28.83 of Olema Pharmaceuticals, Inc.17
- Dec 19, 2025Exercised options 12,070 shares at $4.08 of Olema Pharmaceuticals, Inc.17
- Dec 19, 2025Exercised options 21,520 shares at $7.84 of Olema Pharmaceuticals, Inc.17
- Dec 19, 2025Exercised options 21,520 shares at $3.61 of Olema Pharmaceuticals, Inc.17
- Dec 19, 2025Exercised options 209,690 shares at $4.41 of Olema Pharmaceuticals, Inc.17
- Dec 5, 2025Sold 3,400 shares at $108.05 of Guardant Health20
- Dec 5, 2025Sold 17,055 shares at $107.27 of Guardant Health20
- Dec 5, 2025Sold 8,156 shares at $106.67 of Guardant Health20
- Dec 5, 2025Exercised options 10,703 shares at $31.84 of Guardant Health20
- Dec 5, 2025Exercised options 8,803 shares at $38.01 of Guardant Health20
- Dec 5, 2025Exercised options 9,105 shares at $38.42 of Guardant Health20
- Aug 1, 2025Granted 7,000 shares of BioMarin Pharmaceutical21
- Jul 8, 2025Exercised options 17,248 shares at $4.74 of GoodRx13
- Jun 17, 2025Sold 6,672 shares at $48.38 of Guardant Health22
- Jun 12, 2025Exercised options 8,088 shares of Guardant Health23
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARGoodRx, Board member
- 4
- 5
- 6SEC EDGARGuardant Health, Board member
- 7
- 8
- 9SEC EDGARAgios Pharmaceuticals, Board member
- 10SEC EDGARKite Pharma, Board member
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18SEC EDGARForm 4 filed Jun 22, 2026
- 19SEC EDGARForm 4 filed May 22, 2026
- 20SEC EDGARForm 4 filed Dec 8, 2025
- 21SEC EDGARForm 4 filed Aug 5, 2025
- 22SEC EDGARForm 4 filed Jun 20, 2025
- 23SEC EDGARForm 4 filed Jun 16, 2025